Afuco™ Anti-CMV ADCC Therapeutic Antibody (Sevirumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CMV. Sevirumab (MSL-109) is a human monoclonal antibody for the treatment of infections with cytomegalovirus in patients with AIDS.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-162 |
| Pricing | Inquiry |
| Host | Human |
| Target | CMV |
| Species Reactivity | Cytomegalovirus |
| Type | ADCC enhanced antibody |
| Applications | IF, IP, Neut, FuncS, ELISA, FC |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |